Patients lose use of their extremities as this degenerative disease kills nerves in feet, lower legs, hands, arms. We are leading the way in medical research to cure this debilitating disease and improving the quality of life for people with CMT.
Charcot-Marie-Tooth disease is a genetic nerve disease that affects some 2.8 million people worldwide. A progressive disease, CMT destroys the long nerves to the legs/feet and arms/hands, creating muscle weakness and/or sensory loss. As the nerves die, the muscles around them wither. Muscle imbalance causes the bones of the feet to lose their shape, making standing, walking and balancing a challenge. Hand function is also affected. Other symptoms may include tripping, high arches, foot drop, loss of proprioception, fatigue and chronic pain. CMT is currently incurable, but not usually fatal, though it can be severely disabling.
The CMTA is committed to improving the quality of life for those with CMT, supporting the development of new drugs to treat CMT, and, ultimately, finding a cure for CMT. We are here to offer you support, information and the promise of a better tomorrow. Our vision is a world without CMT.